On the changes of plasmin activity caused by radiation treatment in cancer patients and effects of antiplasmin (ipsilon) administration.
D000933:Antifibrinolytic Agents; D005341:Fibrinolysin / Q000528:radiation effects*; D006801:Humans; D009369:Neoplasms / Q000532:radiotherapy*; D011827:Radiation; D011832:Radiation Injuries / Q000097:blood*; D000979:alpha-2-Antiplasmin
D000933:Antifibrinolytic Agents; D000979:alpha-2-Antiplasmin; D005341:Fibrinolysin
FIBRINOLYSIN/radiation effects; NEOPLASMS/radiotherapy; RADIATION INJURY/blood